These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer. Fleck M, Zhang HG, Kern ER, Hsu HC, Müller-Ladner U, Mountz JD. Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936 [Abstract] [Full Text] [Related]
6. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Lüscher TF. Circulation; 2006 Apr 18; 113(15):1879-87. PubMed ID: 16606788 [Abstract] [Full Text] [Related]
7. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer. Kettunen HL, Kettunen AS, Rautonen NE. Cancer Res; 2003 Aug 15; 63(16):5136-42. PubMed ID: 12941845 [Abstract] [Full Text] [Related]
8. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE. Cancer Res; 2006 Jan 01; 66(1):57-61. PubMed ID: 16397216 [Abstract] [Full Text] [Related]
10. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo. Yoshimoto Y, Kawada M, Ikeda D, Ishizuka M. Int Immunopharmacol; 2005 Feb 01; 5(2):281-8. PubMed ID: 15652759 [Abstract] [Full Text] [Related]
11. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer. Hong NM, Masuko-Hongo K, Sasakawa H, Kato T, Shirai T, Okumura K, Nishioka K, Kobata T. J Autoimmun; 1998 Aug 01; 11(4):301-7. PubMed ID: 9776707 [Abstract] [Full Text] [Related]
13. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity. Shimizu M, Fontana A, Takeda Y, Yoshimoto T, Tsubura A, Matsuzawa A. Cell Immunol; 2001 Jan 10; 207(1):41-8. PubMed ID: 11161452 [Abstract] [Full Text] [Related]
14. Involvement of IL-17 in Fas ligand-induced inflammation. Umemura M, Kawabe T, Shudo K, Kidoya H, Fukui M, Asano M, Iwakura Y, Matsuzaki G, Imamura R, Suda T. Int Immunol; 2004 Aug 10; 16(8):1099-108. PubMed ID: 15237105 [Abstract] [Full Text] [Related]
15. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels. Sata M, Walsh K. J Mol Cell Cardiol; 2000 Aug 10; 32(8):1395-400. PubMed ID: 10900166 [Abstract] [Full Text] [Related]
17. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Clarke AR, Cummings MC, Harrison DJ. Oncogene; 1995 Nov 02; 11(9):1913-20. PubMed ID: 7478622 [Abstract] [Full Text] [Related]
18. Fas- and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma. Yamamoto T, Yokozeki H, Nishioka K. Arch Dermatol Res; 2007 Feb 02; 298(9):465-8. PubMed ID: 17102953 [Abstract] [Full Text] [Related]
19. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. Hunt JS, Vassmer D, Ferguson TA, Miller L. J Immunol; 1997 May 01; 158(9):4122-8. PubMed ID: 9126971 [Abstract] [Full Text] [Related]
20. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Dupont PJ, Warrens AN. Immunology; 2007 Jan 01; 120(1):133-9. PubMed ID: 17233740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]